Market Closed -
Nyse
04:00:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
18.8
USD
|
+2.51%
|
|
+4.56%
|
-5.05%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
17,061
|
16,275
|
19,455
|
13,476
|
10,832
|
13,230
|
-
|
-
|
Enterprise Value (EV)
1 |
23,268
|
22,528
|
25,467
|
19,902
|
17,539
|
21,782
|
21,921
|
21,770
|
P/E ratio
|
383
x
|
39.3
x
|
38.8
x
|
27.3
x
|
35.4
x
|
48.4
x
|
31.8
x
|
40.2
x
|
Yield
|
4.29%
|
4.9%
|
3.33%
|
4.79%
|
6.06%
|
6.41%
|
6.56%
|
6.87%
|
Capitalization / Revenue
|
8.58
x
|
9.99
x
|
10.5
x
|
6.61
x
|
5.02
x
|
4.89
x
|
4.55
x
|
4.38
x
|
EV / Revenue
|
11.7
x
|
13.8
x
|
13.7
x
|
9.77
x
|
8.12
x
|
8.04
x
|
7.54
x
|
7.21
x
|
EV / EBITDA
|
22.7
x
|
46.3
x
|
25.8
x
|
20.9
x
|
15.1
x
|
14.1
x
|
13.1
x
|
12.5
x
|
EV / FCF
|
-18.4
x
|
3,483
x
|
348
x
|
-
|
-
|
22.2
x
|
90.7
x
|
64.6
x
|
FCF Yield
|
-5.43%
|
0.03%
|
0.29%
|
-
|
-
|
4.51%
|
1.1%
|
1.55%
|
Price to Book
|
2.77
x
|
2.4
x
|
2.99
x
|
2.06
x
|
1.71
x
|
1.36
x
|
1.54
x
|
1.78
x
|
Nbr of stocks (in thousands)
|
494,954
|
538,361
|
539,072
|
537,540
|
547,074
|
703,733
|
-
|
-
|
Reference price
2 |
34.47
|
30.23
|
36.09
|
25.07
|
19.80
|
18.80
|
18.80
|
18.80
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/8/22
|
2/7/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,988
|
1,628
|
1,858
|
2,038
|
2,159
|
2,708
|
2,906
|
3,020
|
EBITDA
1 |
1,025
|
487
|
986.8
|
954.1
|
1,162
|
1,547
|
1,673
|
1,746
|
EBIT
1 |
365.1
|
348.3
|
302.5
|
243.5
|
412.1
|
576.4
|
687.4
|
711.5
|
Operating Margin
|
18.37%
|
21.39%
|
16.28%
|
11.95%
|
19.09%
|
21.29%
|
23.66%
|
23.56%
|
Earnings before Tax (EBT)
1 |
51.42
|
217.7
|
128.4
|
-
|
314.9
|
229.9
|
353.8
|
215.2
|
Net income
1 |
43.99
|
411.1
|
502.3
|
497.8
|
304.3
|
228.1
|
363.4
|
239.1
|
Net margin
|
2.21%
|
25.25%
|
27.03%
|
24.43%
|
14.09%
|
8.43%
|
12.51%
|
7.92%
|
EPS
2 |
0.0900
|
0.7700
|
0.9300
|
0.9200
|
0.5600
|
0.3888
|
0.5919
|
0.4677
|
Free Cash Flow
1 |
-1,264
|
6.468
|
73.21
|
-
|
-
|
981.8
|
241.8
|
336.9
|
FCF margin
|
-63.57%
|
0.4%
|
3.94%
|
-
|
-
|
36.26%
|
8.32%
|
11.16%
|
FCF Conversion (EBITDA)
|
-
|
1.33%
|
7.42%
|
-
|
-
|
63.45%
|
14.45%
|
19.29%
|
FCF Conversion (Net income)
|
-
|
1.57%
|
14.58%
|
-
|
-
|
430.33%
|
66.54%
|
140.9%
|
Dividend per Share
2 |
1.480
|
1.480
|
1.200
|
1.200
|
1.200
|
1.206
|
1.233
|
1.292
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/8/22
|
2/7/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
474.7
|
477.3
|
492.9
|
512.4
|
514.4
|
518.1
|
519.5
|
540.2
|
550.9
|
548.7
|
600.8
|
734.8
|
740.1
|
747.3
|
718
|
EBITDA
1 |
256.1
|
252
|
261.8
|
272.6
|
275.6
|
220.2
|
271.9
|
292.4
|
295.1
|
302.7
|
333.8
|
410.2
|
407.4
|
417.1
|
412.1
|
EBIT
1 |
-
|
73.9
|
84.07
|
92.12
|
102.5
|
41.02
|
92.66
|
94.8
|
110.5
|
114.2
|
114.6
|
152.7
|
179.2
|
187.5
|
195.1
|
Operating Margin
|
-
|
15.48%
|
17.06%
|
17.98%
|
19.92%
|
7.92%
|
17.83%
|
17.55%
|
20.06%
|
20.81%
|
19.07%
|
20.78%
|
24.22%
|
25.09%
|
27.18%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
133
|
54.61
|
67.34
|
-
|
22.5
|
87.51
|
88.78
|
93.28
|
127.5
|
Net income
1 |
54.44
|
28.49
|
69.64
|
68.06
|
353.4
|
6.388
|
117.7
|
51.75
|
64.05
|
70.79
|
6.477
|
60.71
|
73.75
|
78.48
|
71.22
|
Net margin
|
11.47%
|
5.97%
|
14.13%
|
13.28%
|
68.69%
|
1.23%
|
22.66%
|
9.58%
|
11.63%
|
12.9%
|
1.08%
|
8.26%
|
9.97%
|
10.5%
|
9.92%
|
EPS
2 |
0.1000
|
0.0500
|
0.1300
|
0.1300
|
0.6500
|
0.0100
|
0.2200
|
0.0900
|
0.1200
|
0.1300
|
0.0100
|
0.0986
|
0.1255
|
0.1301
|
0.1426
|
Dividend per Share
2 |
0.3000
|
0.3000
|
0.3000
|
0.3000
|
0.3000
|
0.3000
|
0.3000
|
0.3000
|
0.3000
|
0.3000
|
0.3000
|
0.3027
|
0.3027
|
0.3031
|
0.3062
|
Announcement Date
|
11/2/21
|
2/8/22
|
5/3/22
|
8/2/22
|
11/1/22
|
2/7/23
|
4/27/23
|
7/27/23
|
10/30/23
|
2/8/24
|
4/25/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
6,207
|
6,254
|
6,012
|
6,426
|
6,707
|
8,552
|
8,690
|
8,540
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
6.056
x
|
12.84
x
|
6.092
x
|
6.735
x
|
5.772
x
|
5.527
x
|
5.195
x
|
4.89
x
|
Free Cash Flow
1 |
-1,264
|
6.47
|
73.2
|
-
|
-
|
982
|
242
|
337
|
ROE (net income / shareholders' equity)
|
0.73%
|
6.39%
|
2.67%
|
7.56%
|
4.68%
|
5.23%
|
5.17%
|
6.16%
|
ROA (Net income/ Total Assets)
|
0.33%
|
2.75%
|
3.22%
|
3.21%
|
1.93%
|
1.31%
|
1.95%
|
1.74%
|
Assets
1 |
13,374
|
14,976
|
15,598
|
15,514
|
15,735
|
17,424
|
18,645
|
13,776
|
Book Value Per Share
2 |
12.40
|
12.60
|
12.10
|
12.20
|
11.60
|
13.90
|
12.20
|
10.60
|
Cash Flow per Share
2 |
-
|
-
|
1.470
|
1.670
|
1.750
|
2.140
|
1.850
|
1.920
|
Capex
1 |
736
|
886
|
722
|
970
|
845
|
497
|
645
|
606
|
Capex / Sales
|
37.02%
|
54.39%
|
38.85%
|
47.61%
|
39.13%
|
18.35%
|
22.19%
|
20.08%
|
Announcement Date
|
2/11/20
|
2/9/21
|
2/8/22
|
2/7/23
|
2/8/24
|
-
|
-
|
-
|
Last Close Price
18.8
USD Average target price
21.72
USD Spread / Average Target +15.53% Consensus |
1st Jan change
|
Capi.
|
---|
| -5.05% | 13.23B | | +4.62% | 55.76B | | -11.72% | 17.72B | | +1.40% | 7.68B | | -16.54% | 5.39B | | +8.62% | 3.28B | | -2.31% | 3.23B | | -5.42% | 3.06B | | -8.15% | 2.73B | | +12.61% | 2.73B |
Healthcare REITs
|